Principal Investigator

Biography 

Dr. Erika Wang earned her PhD in Biomedical Engineering at the University of Toronto under the mentorship of Dr. Milica Radisic, where she developed engineered tissues and organ-on-chip platforms to model cardiac disease. She then pursued her postdoctoral training at the Koch Institute for Integrative Cancer Research at MIT with Dr. Robert Langer and Dr. Ana Jaklenec as a Banting Postdoctoral Fellow, where she integrated micro- and nano-engineering approaches to design programmable drug-delivery systems for tissue regeneration, vaccines, and precision therapeutics. In 2026, she joined the University of Ottawa as a Tier 2 Canada Research Chair in Biomedical Engineering, where she launched the Integrated Biointerfaces Engineering Lab (IBEL). Her lab works at the interface of biomaterials, micro/nanoengineering, tissue engineering, and smart devices to build programmable therapeutic systems, microengineered living tissues, and intelligent microdevices. The overarching goal of her research is to engineer precision biointerfaces across scales to better model disease, control therapeutic delivery, and develop translational technologies for regenerative medicine and human health.